Less invasive surfactant administration in extremely preterm infants: Impact on mortality and morbidity

Neonatology

Volumn 103, Issue 4, 2013, Pages 252-258

  Klebermass Schrehof, Katrin ^a   Wald, Martin ^a   Schwindt, Jens ^a   Grill, Agnes ^a   Prusa, Andrea Romana ^a   Haiden, Nadja ^a   Hayde, Michael ^a   Waldhoer, Thomas ^b   Fuiko, Renate ^a   Berger, Angelika ^a  

^a UNIV KLIN KINDER JUGENDHEILKUNDE   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Continuous positive airway pressure; Less invasive surfactant administration; Morbidity; Mortality; Preterm infant; Respiratory management

Indexed keywords

PORACTANT;

APNEA; ARTICLE; ARTIFICIAL VENTILATION; BRADYCARDIA; BRAIN DAMAGE; BRAIN VENTRICLE HEMORRHAGE; CHRONIC LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; COUGHING; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; ENCEPHALOMALACIA; EXTREMELY PRETERM INFANT; GASTROINTESTINAL SYMPTOM; GESTATIONAL AGE; HOSPITALIZATION; HUMAN; INFANT; LENGTH OF STAY; LESS INVASIVE SURFACTANT; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; PATENT DUCTUS ARTERIOSUS; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PRIORITY JOURNAL; RETROLENTAL FIBROPLASIA; SURVIVAL RATE; BRAIN HEMORRHAGE; FEMALE; LEUKOMALACIA; MALE; NEWBORN MORBIDITY; NEWBORN MORTALITY; OUTCOME ASSESSMENT; THERMAL REGULATING SYSTEM;

AUSTRIA; CATHETERIZATION; CHI-SQUARE DISTRIBUTION; COMBINED MODALITY THERAPY; CONTINUOUS POSITIVE AIRWAY PRESSURE; DRUG ADMINISTRATION ROUTES; FEASIBILITY STUDIES; FEMALE; GESTATIONAL AGE; HOSPITAL MORTALITY; HUMANS; INFANT MORTALITY; INFANT, EXTREMELY PREMATURE; INFANT, NEWBORN; INFUSIONS, PARENTERAL; LUNG; MALE; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84874244081     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000346521     Document Type: Article

References (25)

1. Morley C, Davis PG, Doyle LW, Brion LP, Hascoet JM, Carlin JB, COIN Trial Investigators: Nasal CPAP or intubation at birth for very preterm infants. N Engl J Med 2008; 358: 700-708. (Pubitemid 351240749)
2. Finer NN, Carlo WA, Walsh MC, Rich W, Gantz MG, Laptook AR, Yoder BA, Faix RG, Das A, Poole WK, Donovan EF, Newman NS, Ambalavanan N, Frantz ID 3rd, Buchter S, Sánchez PJ, Kennedy KA, Laroia N, Poindex-ter BB, Cotten CM, Van Meurs KP, Duara S, Narendran V, Sood BG, O'Shea TM, Bell EF, Bhandari V, Watterberg KL, Higgins RD, SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network: Early CPAP versus surfactant in extremely preterm infants. N Engl J Med 2010; 362:1970-1979.
3. Verder H, Robertson B, Greisen G, Ebbesen F, Albertsen P, Lundstrøm K, Jacobsen T, Danish-Swedish Multicenter Study Group: Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. N Engl J Med 1994; 331:1051-1055. (Pubitemid 24317697)
4. Dunn MS, Kaempf J, de Klerk A, de Klerk R, Reilly M, Howard D, Ferrelli K, O'Conor J, Soll RF for the Vermont-Oxford Network DRM Study Group: Randomized trial comparing three approaches to the initial respiratory management of preterm neonates. Pediatrics 2011; 128:e1069-e1076.
5. Seger N, Soll R: Animal-derived surfactant extract for treatment of respiratory distress syndrome. Cochrane Database Syst Rev 2009; 2:CD007836.
6. Yost CC, Soll RF: Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev 2000; 2:CD001456.
7. Stevens TP, Harrington EW, Blennow M, Soll RF: Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev 2007; 17:CD003063.
8. Kattwinkel J, Robinson M, Bloom MT, Del-more P, Ferguson JE: Technique for intrapar-tum administration of surfactant without requirement of an endotracheal tube. J Perina-tol 2004; 24:360-365. (Pubitemid 38931090)
9. Trevisanuto D, Grazzina N, Ferrarese P, Mi-caglio M, Verghese C, Zanardo V: Laryngeal mask airway used as delivery conduit for the administration of surfactant to preterm infants with respiratory distress syndrome. Biol Neonate 2005; 87:217-220. (Pubitemid 41094904)
10. ® combined with nasal CPAP to prevent RDS in preterm neonates. J Aerosol Med Pulm Drug Deliv 2010; 23:303-309.
11. Bohlin K, Gudmundsdottir T, Katz-Salomon M, Jonsson B, Blennow M: Implementation of surfactant treatment during continuous positive airway pressure. J Perinatol 2007; 27:422-427. (Pubitemid 47033755)
12. Sandri F, Plavka R, Ancora G, Simeoni U, Stranak Z, Martinelli S, Mosca F, Nona J, Thomson M, Verder H, Fabbri L, Halliday H, CURPAP Study Group: Prophylactic or early selective surfactant treatment combined with nCPAP in very preterm infants. Pediatrics 2010; 125:e1402-e1409.
13. Kribs A, Pillekamp F, Hünseler C, Vierzig A, Roth B: Early administration of surfactant in spontaneous breathing with nCPAP: feasibility and outcome in extremely premature infants (postmenstrual age ≤ 27 weeks). Pediatr Anaesth 2007; 17:364-369. (Pubitemid 46365124)
14. Göpel W, Kribs A, Ziegler A, Laux R, Hoehn T, Wieg C, Siegel J, Avenarius S, von der Wense A, Vochem M, Groneck P, Weller U, Möller J, Härtel C, Haller S, Roth B, Herting E, on behalf of the German Neonatal Network: Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial. Lancet 2011; 378:1627-1634.
15. Dargaville PA, Aiyappan A, Cornelius A, Williams C, De Paoli AG: Preliminary evaluation of a new technique of minimally invasive surfactant therapy. Arch Dis Child Fetal Neonatal Ed 2011; 96:F243-F248.
16. Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, Brotherton T: Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg 1978; 187:1-7.
17. Papile LN, Burnstein J, Burnstein R, Koffler H: Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weight less than 1, 500 g. J Pediatr 1978; 92:529-534. (Pubitemid 8293290)
18. De Vries LS, Eken P, Dubowitz LMS: The spectrum of leucomalacia using cranial ultrasound. Behav Brain Res 1992; 49:1-6.
19. International Committee for the Classification of Retinopathy of Prematurity: The international classification of retinopathy of prematurity, revisited. Arch Ophthalmol 2005; 123:991-999.
20. Bayley N: Manual of Bayley Scales of Infant Development. II. San Antonio, Psychological Corp, 1993.
21. Amiel-Tison C: Neuromotor status; in Taeusch HW, Yogman MW (eds): Follow-Up Management of the High-Risk Infant. Boston, Little, Brown, 1987, pp 115-126.
22. Bax M, Goldstein M, Rosenbaum P, Leviton A, Paneth N, Dan B, Jacobsson B, Damiano D, Executive Committee for the Definition of Cerebral Palsy: Proposed definition and classification of cerebral palsy, April 2005. Dev Med Child Neurol 2005; 47:571-576. (Pubitemid 41131619)
23. Kribs A, Vierzig A, Hünseler C, Eifinger F, Welzing L, Stützer H, Roth B: Early surfactant in spontaneously breathing with nCPAP in ELBW infants-a single-centre four-year experience. Acta Paediatr 2008; 97:293-298. (Pubitemid 351514153)
24. Dargaville PA, Aiyappan A, De Paoli AG, Kuschel CA, Kamlin CO, Carlin JB, Davis PG: Minimally invasive surfactant therapy in pre-term infants on continuous positive airway pressure. Arch Dis Child Fetal Neoantal Ed 2012 (E-pub ahead of print).
25. Okumura A, Hayakawa F, Kato T, Itomi K, Maruyama K, Ishihara N, Kubota T, Suzuki M, Sato Y, Kuno K, Watanabe K: Hypocarbia in preterm infants with periventricular leuko-malacia: the relation between hypocarbia and mechanical ventilation. Pediatrics 2001; 107: 469-475. (Pubitemid 32183178)